ページェット病治療の世界市場レポート 2025年

ページェット病治療市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.9%で25億7,000万米ドルに成長します。予測期間中の成長は、標的療法に対する需要の高まり、ヘルスケア支出の増加、高齢化人口の増加、新規療法の臨床試験の増加、個別化医療への注目の高まりなどに起因すると考えられます。この期間の主な動向としては、治療選択肢の進歩、生物学的治療へのシフト、併用療法の開発、デジタルヘルスソリューションの統合、診断技術の進歩などが挙げられます。

関節炎の症例数と骨損傷の増加は、ページェット病治療市場の成長を促進すると予想されます。関節炎は関節の炎症を引き起こす疾患で、骨の損傷もその開発の一因となります。これらの疾患の増加は、運動不足と関連しており、筋肉や関節を弱め、動きをサポートし衝撃を吸収する能力を低下させる。その結果、時間の経過とともに関節の変性、こわばり、骨折のリスクが高まる。ページェット病治療は、骨疼痛の緩和、関節機能の改善、異常な骨リモデリングによる骨折や変形などの合併症の予防など、関節炎や骨損傷の管理に重要な役割を果たしています。例えば、2024年2月、米国を拠点とする公衆衛生機関である疾病対策予防センター（CDC）は、2022年、18歳以上の成人の診断された関節炎の年齢調整有病率は18.9％で、男性（16.1％）よりも女性（21.5％）の方が高い発症率を示したと報告しました。関節炎の有病率は年齢とともに増加し、18～34歳の3.6％から75歳以上の53.9％に及ぶ。このような関節炎や骨損傷の増加が、パジェット病治療に対する需要を牽引しています。

ページェット病治療市場の各社は、治療効果の向上、患者の転帰の改善、市場でのプレゼンス拡大のため、カルシウム調整剤などの革新的製品の開発に注力しています。カルシウム調整剤とは、血液中や骨中のカルシウム濃度をコントロールし、様々な生理機能を支えるバランスを維持するのを助ける薬や物質です。例えば、2025年2月、ドイツのヘルスケア企業であるフレゼニウス・カビAGは、症候性骨ページェット病、高カルシウム血症、閉経後骨粗鬆症の治療を目的としたカルシウム調整剤であるカルシトニンサルモン注射液USP合成を発売しました。今回の上市は、より費用対効果の高い治療選択肢を提供し、サプライチェーンを強化し、ジェネリック注射剤のポートフォリオを拡大することを目的としています。フレゼニウス・カビはまた、必要不可欠な医薬品の安定供給を確保するため、施設に大規模な投資を行っており、患者ケアの向上とリーディング・ヘルスケア・プロバイダーとしての地位の確立を目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のページェット病治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のページェット病治療市場：成長率分析
• 世界のページェット病治療市場の実績：規模と成長, 2019-2024
• 世界のページェット病治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界のページェット病治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のページェット病治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アクトネル
• レクラスト
• ゾレドロン酸
• フォサマックス
• ミアカルシン
• アレディア
• カルシトニン
• ゾメタ
• その他の治療法
• 世界のページェット病治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 静脈内
• 外用
• 世界のページェット病治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• ドラッグストア
• 世界のページェット病治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、アクトネル、実績と予測, 2019-2024, 2024-2029F, 2034F
• リセドロン酸ナトリウム錠
• 遅延放出リセドロネート
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、レクラスト、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内レクラスト
• 年1回のレクラスト点滴
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、ゾレドロン酸、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゾレドロン酸5mg注射剤
• ゾレドロン酸4mg注射剤
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、フォサマックス、実績と予測, 2019-2024, 2024-2029F, 2034F
• アレンドロン酸ナトリウム錠
• アレンドロン酸経口液
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、ミアカルシン、実績と予測, 2019-2024, 2024-2029F, 2034F
• ミアカルシン点鼻スプレー
• ミアカルシン注射剤
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、アレディア、実績と予測, 2019-2024, 2024-2029F, 2034F
• パミドロン酸二ナトリウム30mg注射液
• パミドロン酸二ナトリウム90mg注射液
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、カルシトニン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成サーモンカルシトニン
• ヒトカルシトニン
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、ゾメタ、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゾメタ4mg/5mL濃縮液
• ゾメタ4mg点滴
• 世界のページェット病治療市場：タイプ別サブセグメンテーション、その他の治療法、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理薬
• 理学療法
• 外科的介入

第7章 地域別・国別分析

• 世界のページェット病治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のページェット病治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ページェット病治療市場：競合情勢
• ページェット病治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Fresenius Kabi AG
• Zimmer Biomet Holdings Inc.
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Limited
• Apotex Inc.
• Sumitomo Pharma Co. Ltd.
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Endo International plc
• Zaklady Farmaceutyczne Polpharma S.A.
• Abiogen Pharma S.p.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ページェット病治療市場2029：新たな機会を提供する国
• ページェット病治療市場2029：新たな機会を提供するセグメント
• ページェット病治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Paget's disease is a chronic bone disorder marked by abnormal bone remodeling, which leads to weakened and enlarged bones. Treatment generally includes medications to regulate bone metabolism and manage symptoms, pain relievers, and, in some cases, surgery to address severe bone deformities.

The primary treatments for Paget's disease include Actonel, Reclast, Zoledronic acid, Fosamax, Miacalcin, Aredia, Calcitonin, Zometa, and other therapies. Actonel is a brand name for risedronate, a medication used to treat and prevent osteoporosis by strengthening bones. These treatments are administered through various routes, such as oral, intravenous, and topical, and are distributed via different channels, including hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. The key end users of these treatments are hospitals, clinics, and other healthcare providers.

The paget disease treatment market research report is one of a series of new reports from The Business Research Company that provides paget disease treatment market statistics, including the paget disease treatment industry global market size, regional shares, competitors with the paget disease treatment market share, detailed paget disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the paget disease treatment industry. This paget disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The paget disease treatment market size has grown steadily in recent years. It will grow from $2.12 billion in 2024 to $2.21 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth during the historic period can be attributed to the rising prevalence of Paget's disease, increased awareness and diagnosis rates, an aging population, the expansion of healthcare infrastructure, and the growing adoption of bisphosphonates.

The paget disease market size is expected to see steady growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth during the forecast period can be attributed to the rising demand for targeted therapies, increasing healthcare expenditure, a growing aging population, more clinical trials for novel therapies, and a greater focus on personalized medicine. Key trends during this period include advancements in treatment options, a shift toward biologic treatments, the development of combination therapies, the integration of digital health solutions, and progress in diagnostic technologies.

The growing number of arthritis cases and bone injuries is expected to drive the growth of the Paget disease treatment market. Arthritis is a condition that causes joint inflammation, while bone injuries can also contribute to its development. The rise in these conditions is linked to physical inactivity, which weakens muscles and joints, reducing their ability to support movement and absorb impact. This leads to an increased risk of joint degeneration, stiffness, and fractures over time. Paget disease treatment plays a crucial role in managing arthritis and bone injuries by alleviating bone pain, improving joint function, and preventing complications such as fractures and deformities caused by abnormal bone remodeling. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health institute, reported that in 2022, the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9%, with women (21.5%) showing a higher incidence than men (16.1%). The prevalence of arthritis increases with age, ranging from 3.6% in individuals aged 18-34 to 53.9% in those aged 75 and older. This rise in arthritis and bone injuries is driving the demand for Paget disease treatments.

Companies in the Paget disease treatment market are focusing on developing innovative products, such as calcium regulators, to improve treatment efficacy, enhance patient outcomes, and expand their market presence. A calcium regulator is a medication or substance that helps control calcium levels in the blood and bones, maintaining balance to support various physiological functions. For example, in February 2025, Fresenius Kabi AG, a Germany-based healthcare company, introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator designed to treat symptomatic Paget's disease of the bone, hypercalcemia, and postmenopausal osteoporosis. This launch aims to provide a more cost-effective treatment option, strengthen their supply chain, and expand their portfolio of generic injectables. Fresenius Kabi has also invested significantly in its facilities to ensure a steady supply of essential medicines, aiming to enhance patient care and solidify its position as a leading healthcare provider.

In June 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Taro Pharmaceutical for approximately $347.73 million. This acquisition was intended to give Sun Pharma full control of Taro Pharmaceutical Industries Ltd., boosting its dermatology and specialty generics portfolio while streamlining operations and maximizing synergies. Taro Pharmaceutical Industries Ltd., an Israel-based company, specializes in generic and specialty medicines, including treatments for Paget's disease.

Major players in the paget disease treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Apotex Inc., Sumitomo Pharma Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Endo International plc, Zaklady Farmaceutyczne Polpharma S.A., Abiogen Pharma S.p.A.

North America was the largest region in the paget disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in paget disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the paget disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The paget disease treatment market consists of revenues earned by entities by providing services such as diagnosis services, orthopedic services, genetic counseling services, and follow-up and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The paget disease treatment market also includes sales of pain management medications, calcium and vitamin D supplements, bone density monitoring devices, and assistive devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paget Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paget disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for paget disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paget disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Actonel; Reclast; Zoledronic Acid; Fosamax; Miacalcin; Aredia; Calcitonin; Zometa; Other Treatments
• 2) By Route Of Administration: Oral; Intravenous; Topical
• 3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Pharmacie; Drug stores
• 4) By End User: Hospitals; Clinics; Other End-Users
• Sub Segments:
• 1) By Actonel: Risedronate Sodium Tablets; Delayed-Release Risedronate.
• 2) By Reclast: Intravenous Reclast; Annual Reclast Infusion.
• 3) By Zoledronic Acid: Zoledronic Acid 5 mg Injection; Zoledronic Acid 4 mg Injection.
• 4) By Fosamax: Alendronate Sodium Tablets; Alendronate Oral Solution
• 5) By Miacalcin: Miacalcin Nasal Spray; Miacalcin Injection
• 6) By Aredia: Pamidronate Disodium 30 mg Injection; Pamidronate Disodium 90 mg Injection
• 7) By Calcitonin: Synthetic Salmon Calcitonin; Human Calcitonin
• 8) By Zometa: Zometa 4 mg/5 mL Concentrate; Zometa 4 mg Infusion
• 9) By Other Treatments: Pain Management Medications; Physical Therapy; Surgical Interventions
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Takeda Pharmaceutical Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Paget Disease Treatment Market Characteristics

3. Paget Disease Treatment Market Trends And Strategies

4. Paget Disease Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Paget Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Paget Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Paget Disease Treatment Market Growth Rate Analysis
• 5.4. Global Paget Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Paget Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Paget Disease Treatment Total Addressable Market (TAM)

6. Paget Disease Treatment Market Segmentation

• 6.1. Global Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Actonel
• Reclast
• Zoledronic Acid
• Fosamax
• Miacalcin
• Aredia
• Calcitonin
• Zometa
• Other Treatments
• 6.2. Global Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Topical
• 6.3. Global Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacie
• Drug stores
• 6.4. Global Paget Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-Users
• 6.5. Global Paget Disease Treatment Market, Sub-Segmentation Of Actonel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Risedronate Sodium Tablets
• Delayed-Release Risedronate
• 6.6. Global Paget Disease Treatment Market, Sub-Segmentation Of Reclast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Reclast
• Annual Reclast Infusion
• 6.7. Global Paget Disease Treatment Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zoledronic Acid 5 mg Injection
• Zoledronic Acid 4 mg Injection
• 6.8. Global Paget Disease Treatment Market, Sub-Segmentation Of Fosamax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alendronate Sodium Tablets
• Alendronate Oral Solution
• 6.9. Global Paget Disease Treatment Market, Sub-Segmentation Of Miacalcin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Miacalcin Nasal Spray
• Miacalcin Injection
• 6.10. Global Paget Disease Treatment Market, Sub-Segmentation Of Aredia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pamidronate Disodium 30 mg Injection
• Pamidronate Disodium 90 mg Injection
• 6.11. Global Paget Disease Treatment Market, Sub-Segmentation Of Calcitonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Salmon Calcitonin
• Human Calcitonin
• 6.12. Global Paget Disease Treatment Market, Sub-Segmentation Of Zometa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zometa 4 mg/5 mL Concentrate
• Zometa 4 mg Infusion
• 6.13. Global Paget Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management Medications
• Physical Therapy
• Surgical Interventions

7. Paget Disease Treatment Market Regional And Country Analysis

• 7.1. Global Paget Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Paget Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Paget Disease Treatment Market

• 8.1. Asia-Pacific Paget Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Paget Disease Treatment Market

• 9.1. China Paget Disease Treatment Market Overview
• 9.2. China Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Paget Disease Treatment Market

• 10.1. India Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Paget Disease Treatment Market

• 11.1. Japan Paget Disease Treatment Market Overview
• 11.2. Japan Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Paget Disease Treatment Market

• 12.1. Australia Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Paget Disease Treatment Market

• 13.1. Indonesia Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Paget Disease Treatment Market

• 14.1. South Korea Paget Disease Treatment Market Overview
• 14.2. South Korea Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Paget Disease Treatment Market

• 15.1. Western Europe Paget Disease Treatment Market Overview
• 15.2. Western Europe Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Paget Disease Treatment Market

• 16.1. UK Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Paget Disease Treatment Market

• 17.1. Germany Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Paget Disease Treatment Market

• 18.1. France Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Paget Disease Treatment Market

• 19.1. Italy Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Paget Disease Treatment Market

• 20.1. Spain Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Paget Disease Treatment Market

• 21.1. Eastern Europe Paget Disease Treatment Market Overview
• 21.2. Eastern Europe Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Paget Disease Treatment Market

• 22.1. Russia Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Paget Disease Treatment Market

• 23.1. North America Paget Disease Treatment Market Overview
• 23.2. North America Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Paget Disease Treatment Market

• 24.1. USA Paget Disease Treatment Market Overview
• 24.2. USA Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Paget Disease Treatment Market

• 25.1. Canada Paget Disease Treatment Market Overview
• 25.2. Canada Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Paget Disease Treatment Market

• 26.1. South America Paget Disease Treatment Market Overview
• 26.2. South America Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Paget Disease Treatment Market

• 27.1. Brazil Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Paget Disease Treatment Market

• 28.1. Middle East Paget Disease Treatment Market Overview
• 28.2. Middle East Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Paget Disease Treatment Market

• 29.1. Africa Paget Disease Treatment Market Overview
• 29.2. Africa Paget Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Paget Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Paget Disease Treatment Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Paget Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Paget Disease Treatment Market Competitive Landscape
• 30.2. Paget Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Paget Disease Treatment Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Mylan N.V.
• 31.4. Fresenius Kabi AG
• 31.5. Zimmer Biomet Holdings Inc.
• 31.6. Eisai Co. Ltd.
• 31.7. Sun Pharmaceutical Industries Limited
• 31.8. Apotex Inc.
• 31.9. Sumitomo Pharma Co. Ltd.
• 31.10. Aurobindo Pharma Limited
• 31.11. Dr. Reddy's Laboratories Ltd.
• 31.12. Cipla Limited
• 31.13. Endo International plc
• 31.14. Zaklady Farmaceutyczne Polpharma S.A.
• 31.15. Abiogen Pharma S.p.A.

32. Global Paget Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Paget Disease Treatment Market

34. Recent Developments In The Paget Disease Treatment Market

35. Paget Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Paget Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Paget Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Paget Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer